Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37
Authors
Keywords
Vancomycin, Linezolid, Daptomycin, Survival Ratio, Ceftaroline
Journal
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume 35, Issue 9, Pages 1441-1447
Publisher
Springer Nature
Online
2016-05-27
DOI
10.1007/s10096-016-2682-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia
- (2013) K. W. McConeghy et al. CLINICAL INFECTIOUS DISEASES
- Cathelicidins: Peptides with Antimicrobial, Immunomodulatory, Anti- Inflammatory, Angiogenic, Anticancer and Procancer Activities
- (2013) Jack Wong et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
- (2013) George Sakoulas et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Pharmacological Inhibition of the ClpXP Protease Increases Bacterial Susceptibility to Host Cathelicidin Antimicrobial Peptides and Cell Envelope-Active Antibiotics
- (2012) Shauna M. McGillivray et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A comprehensive summary of LL-37, the factotum human cathelicidin peptide
- (2012) Dieter Vandamme et al. CELLULAR IMMUNOLOGY
- Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia?
- (2011) Shinwon Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
- (2011) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
- (2011) Marin L Schweizer et al. BMC INFECTIOUS DISEASES
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
- (2011) Natasha E. Holmes et al. JOURNAL OF INFECTIOUS DISEASES
- Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability
- (2010) Fitzroy J. Byfield et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality: A Retrospective Cohort Study
- (2010) Marin L. Schweizer et al. PLoS One
- Low Plasma Level of Cathelicidin Antimicrobial Peptide (hCAP18) Predicts Increased Infectious Disease Mortality in Patients Undergoing Hemodialysis
- (2009) Adrian F. Gombart et al. CLINICAL INFECTIOUS DISEASES
- Color me bad: microbial pigments as virulence factors
- (2009) George Y. Liu et al. TRENDS IN MICROBIOLOGY
- The roles of cathelicidin LL-37 in immune defences and novel clinical applications
- (2008) Anastasia Nijnik et al. CURRENT OPINION IN HEMATOLOGY
- Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus
- (2008) K. Ouhara et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started